3/A

FORM 3/A SUBMISSION

Company: Emmaus Life Sciences, Inc.
Filed: July 25, 2019
Period of Report: July 17, 2019
Accession Number: 0001209191-19-043237

View Document ↗ View on SEC.gov ↗